Service: Advisory and Business Consulting

The False Claims Act: The Sheriff is Back in Town

As regulations and requirements for transparent interactions between pharmaceutical, medical device and biotechnology companies (collectively “life sciences organizations” or “LSOs”), and healthcare professionals (“HCPs”) continue to evolve, certain patterns are emerging. It is becoming increasingly important to protect prescribers and companies by ensuring that transactions are commercially reasonable and FMV compliant.

eDiscovery or Digital Forensics?

Here’s a brief explanation and comparison of both, as well as a few key reasons that it’s important to know the difference and choose the right experts carefully.

Call Coverage Arrangements

Here are a few key concepts and questions to consider when structuring and supporting an on-call arrangement.

Merger and Acquisition Due Diligence Best Practices

When potential acquirers look at a prospective business, inventory quantity and valuation are common risk areas. What follows here are some questions for leadership to ask to determine if they’re ready for an opportunity to sell.